Matches in Wikidata for { <http://www.wikidata.org/entity/Q105493891> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q105493891 description "clinical trial" @default.
- Q105493891 description "ensayo clínico" @default.
- Q105493891 description "ensayu clínicu" @default.
- Q105493891 description "klinisch onderzoek" @default.
- Q105493891 description "клінічне випробування" @default.
- Q105493891 description "临床试验" @default.
- Q105493891 name "Study of Efficacy and Safety of Voretigene Neparvovec in Japanese Patients With Biallelic RPE65 Mutation-associated Retinal Dystrophy" @default.
- Q105493891 name "Study of Efficacy and Safety of Voretigene Neparvovec in Japanese Patients With Biallelic RPE65 Mutation-associated Retinal Dystrophy" @default.
- Q105493891 type Item @default.
- Q105493891 label "Study of Efficacy and Safety of Voretigene Neparvovec in Japanese Patients With Biallelic RPE65 Mutation-associated Retinal Dystrophy" @default.
- Q105493891 label "Study of Efficacy and Safety of Voretigene Neparvovec in Japanese Patients With Biallelic RPE65 Mutation-associated Retinal Dystrophy" @default.
- Q105493891 prefLabel "Study of Efficacy and Safety of Voretigene Neparvovec in Japanese Patients With Biallelic RPE65 Mutation-associated Retinal Dystrophy" @default.
- Q105493891 prefLabel "Study of Efficacy and Safety of Voretigene Neparvovec in Japanese Patients With Biallelic RPE65 Mutation-associated Retinal Dystrophy" @default.
- Q105493891 P1132 Q105493891-72B1D8AB-E23B-4E42-B80A-D0328D8AD9A2 @default.
- Q105493891 P1476 Q105493891-B164A88D-301A-4EF9-B1A7-0305878F0C48 @default.
- Q105493891 P17 Q105493891-FF4762FC-C5F0-45D7-B579-9333D4CCF2B1 @default.
- Q105493891 P2899 Q105493891-0CC77A7B-860B-466B-8BB8-9C3F1BFE329E @default.
- Q105493891 P3098 Q105493891-B0227E44-64AA-489B-B33B-74AC699F90CD @default.
- Q105493891 P31 Q105493891-7F89C443-CC31-476E-8C25-13BE8E20FB4D @default.
- Q105493891 P580 Q105493891-F00325C4-C5BD-4EA8-92D5-D4A8B8227758 @default.
- Q105493891 P582 Q105493891-73A5469B-0F46-4C21-A353-4E98A81BEA27 @default.
- Q105493891 P6099 Q105493891-299528B3-05E0-4F17-AB16-048B49376A53 @default.
- Q105493891 P6153 Q105493891-0A79121B-18AF-4AAB-A815-F2DAF393DC5C @default.
- Q105493891 P8005 Q105493891-74A07EE9-FA14-4DF5-B976-286555A7AEF7 @default.
- Q105493891 P8363 Q105493891-EAA9B5CC-5212-4EEC-B835-CD149E631D27 @default.
- Q105493891 P859 Q105493891-C03AD815-C25C-4C8D-ACCC-327E64DD462C @default.
- Q105493891 P1132 "+4" @default.
- Q105493891 P1476 "An Open-label, Single-arm Study to Provide Efficacy and Safety Data of Voretigene Neparvovec Administered as Subretinal Injection in Japanese Patients With Biallelic RPE65 Mutation-associated Retinal Dystrophy" @default.
- Q105493891 P17 Q17 @default.
- Q105493891 P2899 "+4" @default.
- Q105493891 P3098 "NCT04516369" @default.
- Q105493891 P31 Q30612 @default.
- Q105493891 P580 "2020-11-24T00:00:00Z" @default.
- Q105493891 P582 "2022-03-08T00:00:00Z" @default.
- Q105493891 P6099 Q42824827 @default.
- Q105493891 P6153 Q507154 @default.
- Q105493891 P8005 Q76649708 @default.
- Q105493891 P8363 Q78089383 @default.
- Q105493891 P859 Q507154 @default.